1-832-868-1888
order@swbio.com
Catalog Number: |
49854 |
other_names: | CD 27 antibody CD27 antibody CD27 antigen antibody CD27 molecule antibody CD27_HUMAN antibody CD27L receptor antibody LPFS2 antibody MGC20393 antibody OTTHUMP00000238557 antibody S152 |
Amount: |
100μg |
calculated_mw: | Predicted band size: 29 kDa |
host_species: | Rabbit |
Price: |
$319 |
Swiss-Prot No: |
Swiss-Prot#:P26842 |
Form of Antibody: |
1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
Storage/Stability: |
|
Immunogen: |
Intracellular domain corresponding to Human CD27. |
Purification: |
ProA affinity purified |
Specificity/Sensitivity: |
|
Applications: |
WB,ICC,IHC,FC |
Background: |
The tumor necrosis factor (TNF) receptor family is composed of several type I integral membrane glycoproteins that exhibit homology in their cysteine-rich extracellular domains. Members of this family include FAS, OX40, CD27 and CD30. Ligands for these receptors are often type II transmembrane glycoproteins, as is the case for CD27 and CD30. CD27 is a homodimeric lymphocyte-specific surface antigen present on T and B lymphocytes. Activation of the CD3 complex via the T cell receptor for antigen leads to an increase in CD27 expression. Together, CD27 and its ligand, CD27L, generate co-stimulatory signals required for complete T cell activation. CD30 is a surface marker for neoplastic cells of the Hodgkin's lymphoma and related hematologic malignancies. CD30L has been shown to enhance the proliferation of the Hodgkin's cell line HDLM-2, but exerts antiproliferative effects on large cell anaplastic lymphoma cell lines. |
References: |
|
appl_detail: |
WB: 1:500-1:1,000 |
QUICK LINKS
Unique Antibodies Cancer/Apoptosis antibody Tag Antibody Neuroscience antibody MAP kinase antibody Secondary AntibodyCONTACT US
1-832-868-1888 order@swbio.comGET IN TOUCH